Mturituri Herbal Contraceptive
Abrus Precatorius or Commiphora Africana
- User: Female/Male
- Hormonal: Non-Hormonal
-
Delivery type:
- Not Yet Determined
-
Intended Duration:
- Not Yet Determined
- Development Stage: Pre-Clinical
- Developer(s)/researcher(s): Kenya Institute of Primate Research
Details
- API: Not Yet Determined - Mturituri Derivative
- Target: Not Yet Determined
-
Mechanism of Action:
- Not Yet Determined
- Inactive Materials: Not Yet Determined
- Regimen: Not Yet Determined
- MPT: Not Potential MPT
- Promising Attributes: Developers hope mturituri-based contraceptives would leverage indigenous knowledge to provide a non-hormonal FP option with limited side effects.
Product Status
Developer Confirms Active Intent to Pursue Clinical Evaluation
History
Mturituri, a seed derived from either Abrus Prectorius or Commiphora Africana, has been evaluated in bench studies and through animal research for its contraceptive potential for both male and female users for more than 30 years. This evaluation has been driven by research teams based in Africa and South East Asia, where the seed is used as a traditional medicine with varied applications.
2022: Kenya Institute of Primate Research and KEMRI confirm unpublished animal studies and intent to pursue clinical evaluation of mturituri as an herbal contraceptive method.